Israel Englander Immunocore Holdings PLC Transaction History

Millennium Management LLC

$175 Billion
Q1 2025

A detailed history of Israel Englander (Millennium Management LLC) transactions in Immunocore Holdings PLC stock. As of the latest transaction made, Millennium Management LLC holds 285,270 shares of IMCR stock, worth $11 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

285,270

Previous 573,362 50.25%

Holding current value

$11 Million

Previous $16.9 Million 49.96%

% of portfolio

0.0%

Previous 0.01%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$28.21 - $33.0 $8.13 Million - $9.51 Million	-288,092 Reduced 50.25%	285,270 $8.46 Million
Q4 2024 Feb 14, 2025	SELL	$28.14 - $34.69 $2.91 Million - $3.58 Million	-103,269 Reduced 15.26%	573,362 $16.9 Million
Q3 2024 Nov 14, 2024	BUY	$30.06 - $41.49 $2.27 Million - $3.14 Million	75,677 Added 12.59%	676,631 $21.1 Million
Q2 2024 Aug 14, 2024	BUY	$33.78 - $63.75 $11.3 Million - $21.2 Million	333,167 Added 124.41%	600,954 $20.4 Million
Q1 2024 May 15, 2024	BUY	$60.14 - $75.36 $12.5 Million - $15.7 Million	207,789 Added 346.33%	267,787 $17.4 Million
Q4 2023 Feb 14, 2024	BUY	$42.85 - $69.5 $2.57 Million - $4.17 Million	59,998 New	59,998 $4.1 Million
Q1 2023 May 15, 2023	SELL	$46.12 - $65.71 $10.2 Million - $14.5 Million	-220,125 Reduced 65.18%	117,603 $5.81 Million
Q4 2022 Feb 14, 2023	BUY	$45.51 - $65.08 $8.26 Million - $11.8 Million	181,546 Added 116.24%	337,728 $19.3 Million
Q3 2022 Nov 14, 2022	BUY	$37.34 - $57.44 $5.12 Million - $7.87 Million	137,004 Added 714.38%	156,182 $7.33 Million

Others Institutions Holding IMCR

# of Institutions

128

Shares Held

44.6M

Call Options Held

219K

Put Options Held

125K

View Full List

About Immunocore Holdings plc

Ticker IMCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,897,100
Market Cap $1.7B
Description
Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...

More about IMCR

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account